Hansa Biopharma half year report 2023

Solid product sales in Q2 2023 Collaboration announced in gene therapy with Genethon in Crigler-Najjar syndrome New Eurotransplant desensitization program implemented in June First patient treated in new investigator-initiated Phase 2 study in ANCA-associated vasculitis LUND, Sweden, July…